Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05978050
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-07-20
Brief Title:
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Sponsor:
Biotech Pharmaceutical Co Ltd
Organization:
Biotech Pharmaceutical Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gastric or Esophagogastric Junction Adenocarcinoma |
Keywords: